Comparison
3 Hydroxyisobutyric Aciduria C0342737 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between 3 Hydroxyisobutyric Aciduria and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
3 Hydroxyisobutyric Aciduria C0342737
A rare metabolic condition where the body cannot properly break down certain amino acids. It can cause developmental delay, intellectual disability, and metabolic problems. Management involves dietary modifications and supportive care.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
3 Hydroxyisobutyric Aciduria C0342737
0-5
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
3 Hydroxyisobutyric Aciduria C0342737
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
3 Hydroxyisobutyric Aciduria C0342737
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
3 Hydroxyisobutyric Aciduria C0342737
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
3 Hydroxyisobutyric Aciduria C0342737
metabolic
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
3 Hydroxyisobutyric Aciduria C0342737
metabolic
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
3-hydroxyisobutyric-aciduria-C0342737 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Hydroxyisobutyric Aciduria C0342737 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Developmental delay | May accompany intellectual disability and metabolic problems. | Developmental or learning delay may occur without a primary metabolic illness. | Moderate |
| Metabolic disturbance | Described metabolic problems may occur; triggers and frequency are not established. | Not primarily a metabolic disorder in the supplied description. | High |
| Kidney involvement | Renal disease is not a defining feature in the source data. | Potential kidney involvement is described and needs evaluation. | Moderate |
When to favor each condition
Choose 3 Hydroxyisobutyric Aciduria C0342737 when
Developmental delay with suspected amino-acid metabolism abnormality
This better fits the described metabolic condition, pending confirmatory testing.
Moderate
Early-childhood metabolic problems
Supplied data indicate onset from 0 to 5 years and severe severity.
Moderate
Dietary modification is being considered
The description supports dietary changes and supportive care, without specifying a regimen.
Low
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
A recurrent deletion at 17q12 is identified
A confirmed chromosomal finding directly supports this genetic syndrome.
High
Developmental delay with possible kidney findings
This combination matches the supplied congenital and renal features.
Moderate
Long-term developmental and renal surveillance is needed
Management is described as monitoring plus supportive therapies.
Moderate
How key tests differ
| Test | 3 Hydroxyisobutyric Aciduria C0342737 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Urine organic acid or amino-acid metabolite testing | May suggest abnormal hydroxyisobutyric-related metabolites; no cutoff is established here. | Not expected to establish the chromosomal deletion. | Abnormal results are suggestive only and require specialist confirmation. |
| Chromosomal microarray or equivalent genetic test | Not the primary test for this metabolic condition. | May identify a recurrent 17q12 deletion. | A detected deletion supports the syndrome; a negative result needs clinical review. |
| Renal function tests or imaging | No specific renal abnormality is established by the source. | May be used to assess possible kidney involvement. | Abnormal findings require clinician correlation and do not alone prove the syndrome. |
Prognosis comparison
3 Hydroxyisobutyric Aciduria C0342737
- Outcome
- Chronic and potentially severe, but the individual course is not established.
- Factors
- Metabolic stability, developmental support, and associated complications.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Chronic, with moderate severity in the supplied data; the spectrum may vary.
- Factors
- Developmental needs, neurologic features, and kidney findings.
Time frame: Childhood recognition with long-term follow-up; exact prognosis is not established.
Early specialist care, supportive therapies, and organ-specific monitoring.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental or intellectual disability | Described risk; individual severity is not quantified. Developmental delay is possible, with moderate severity in the supplied classification. Outcomes vary and are not established as uniform. |
| Acute metabolic decompensation | Metabolic problems are possible, but frequency is not established. Not characteristic based on the supplied data. Suspected acute illness needs urgent clinician assessment. |
| Kidney disease | Not established by the source description. Potential involvement warrants monitoring. Do not assume renal disease without evaluation. |
Patient education highlights
- HighConfirming the diagnosis
These are different conditions. Laboratory or genetic results and specialist review determine which applies.
- HighCare approach
Metabolic care may include diet and support; deletion syndrome emphasizes monitoring and therapies. No treatment dose is provided.
- MediumWhen to seek care
Seek urgent advice for lethargy, poor feeding, seizures, or reduced urine output if a clinician has identified concern.